Clinical Trials Logo
  1. Home
  2. Invasive Candidiasis
  3. NCT00672841

β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients

Invasive Candidiasis Clinical Trial

Official title:
Randomized Comparison of β-D-Glucan Surveillance With Preemptive Anidulafungin Versus Standard Care for the Management of Invasive Candidiasis in Surgical Intensive Care Unit Patients

Clinical Trial Summary

This is a single center, prospective, open label assessment of β-D-glucan surveillance with preemptive anidulafungin therapy versus standard care for the prevention of invasive candidiasis in at-risk surgical intensive care unit (SICU) patients. Subjects will be stratified by APACHE II score and randomized in 3:1 fashion to either biweekly surveillance using the β-D-glucan assay or standard care. Subjects in the active monitoring arm will receive intravenous anidulafungin should the β-D-glucan exceed 60 pg/mL on a single determination. Subjects in the standard care arm will have biweekly blood draws for β-D-glucan, but the specimens will be batched and tested retrospectively. Antifungal use in the standard care arm is at the discretion of the treating physicians. The primary study end-points are the feasibility of a preemptive antifungal strategy in a SICU setting, β-D-glucan test characteristics, and the safety and tolerability of preemptive anidulafungin. Risks associated with study participation include the risks associated with blood draws, study drug related side effects, and the potential for loss of confidentiality.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00672841
Study type Interventional
Source Duke University
Contact
Status Completed
Phase N/A
Start date June 2008
Completion date January 2011
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05763251 - Comparison of Uncomplicated Candidemia Therapy Duration in Children N/A
Recruiting NCT01438216 - Anidulafungin Pharmacokinetics in Intensive Care Unit Patients N/A
Terminated NCT01213823 - Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With Echinocandins Phase 4
Completed NCT02491151 - Variability of Fluconazole Concentration in Critically Ill Patients N/A
Completed NCT01716988 - Pharmacokinetics of Micafungin in Critically Ill Patients N/A
Completed NCT00607763 - Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug Phase 1
Completed NCT00608335 - Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug Phase 1
Completed NCT00786903 - Candida Spp. in the Lower Respiratory Tract: Harmless Residents or Pathogen? N/A
Completed NCT00670657 - CRITIC - Treatment of Candidemia and Invasive Candidiasis Phase 4
Recruiting NCT04368559 - Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation Phase 3
Not yet recruiting NCT05707832 - A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus Phase 3
Recruiting NCT03538912 - Early Discontinuation of Empirical Antifungal Therapy and Biomarkers N/A
Completed NCT02801682 - NOBICS - NOvel BIomarker In Invasive CandidiasiS/Candida Sepsis
Completed NCT02164890 - Pharmacokinetics of Micafungin in Patients of Intensive Care Units Phase 4
Completed NCT02841501 - Genetic Susceptibility Factors for Candidemia.
Completed NCT01047267 - Pharmacokinetics of Anidulafungin on Intensive Care Unit (ICU) N/A
Completed NCT02734862 - CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension Phase 2
Completed NCT01773876 - Empirical Antifungal Treatment in ICUS Phase 3
Completed NCT00689338 - Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study Phase 3
Terminated NCT03906916 - Comparison of Two Diagnostic Tests in Patients With Suspected Invasive Candidiasis in Internal Medicine Wards and Who Are Currently Timely Treated With Micafungin Phase 4